<p>Linagliptin is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults.</p>

<ul>
	<li><strong>As monotherapy</strong>: in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance or contraindicated due to renal impairment.</li>
	<li><strong>As combination therapy</strong>: in combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control.</li>
</ul>